Skip to content Skip to sidebar Skip to footer
racura oncology
Actinogen Medical now has cash to reach its pivotal Alzheimer’s readout
Actinogen Medical (ASX:ACW) investment case is a simple trade-off between funding and execution risk over the next seven months and the potential value of Xanamem if its pivotal XanaMIA Alzheimer’s trial delivers in November 2026. That tension eased materially after the company raised $16.8m in February, lifting pro forma cash to about $29.5m and extending…
JORC Resources
JORC Resources: Here’s What’s Crucial For Investors to Know Before Investing
Investors will often hear of JORC Resources or a JORC Code and may think companies are alluding to a mere textbook. It is a strict public reporting standard that governs how mining companies disclose exploration results, Mineral Resources, and Ore Reserves to the market. It exists to protect investors by ensuring statements about a deposit’s size…
online casinos
Why Online Casinos Like Royal Reels Outperform Traditional Gaming Stocks in 2025?
By 2025, the performance gap between online gaming platforms and traditional gaming stocks has become harder to ignore. While land-based casino operators and lottery businesses still generate large, stable revenues, their growth profiles increasingly look constrained compared to digital-first iGaming models. For Australian investors, this raises a practical question. Where does the next leg of…
Computershare
Computershare (ASX:CPU): The Unsung Hero of Market Infrastructure
Although Computershare (ASX:CPU) may not be a name that immediately comes to mind when discussing the big names of the stock market (i.e. the big banks or miners), it has long been deeply entwined in the infrastructure behind the scenes supporting capital markets. It is an unsung hero keeping the monetary system moving safely and…
Brambles (ASX BXB)
Brambles (ASX: BXB): Withstanding The Impacts of Trump’s Tariffs (For Now)
Brambles (ASX: BXB) has significantly outperformed the ASX 200 in the past year, gaining nearly 20% even with the drop during the furore over Trump's tariffs. As a company worth over $30bn that operates across approximately 60 countries worldwide, with its business heavily tied to global trade flows, it is sensitive to tariffs and geopolitical changes…

Stocks Down Under (Pitt Street Research AFSL 1265112) provides actionable investment ideas on ASX-listed stocks. This content provides general information only and does not constitute financial advice. Always do your own research before making investment decisions. © 2026 Stock Down Under. All Rights Reserved.

© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here